Drug Shortage Report for NEUPRO
Report ID | 224297 |
Drug Identification Number | 02403897 |
Brand name | NEUPRO |
Common or Proper name | Neupro 1mg 30 PAT iRT CA |
Company Name | UCB CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | ROTIGOTINE |
Strength(s) | 1MG |
Dosage form(s) | PATCH |
Route of administration | TRANSDERMAL TRANSDERMAL |
Packaging size | 30 |
ATC code | N04BC |
ATC description | |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | 2024-04-02 |
Actual start date | 2024-04-02 |
Estimated end date | 2024-04-16 |
Actual end date | 2024-04-04 |
Shortage status | Resolved |
Updated date | 2024-04-05 |
Company comments | Shortage due to extended lot release review and release process. No Quality event expected. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2201 BRISTOL CIRCLE OAKVILLE, ONTARIO CANADA L6H 0J8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2024-04-05 | English | Compare |
v5 | 2024-04-04 | French | Compare |
v4 | 2024-04-04 | English | Compare |
v3 | 2024-04-04 | French | Compare |
v2 | 2024-04-04 | English | Compare |
v1 | 2024-04-04 | English | Compare |
Showing 1 to 6 of 6